These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 15927253

  • 1. Treatment of elderly patients with acute lymphoblastic leukemia--evidence for a benefit of imatinib in BCR-ABL positive patients.
    Brandwein JM, Gupta V, Wells RA, Schuh AC, Schimmer AD, Lipton JH, Messner HA, Yi QL, Chun K, Kamel-Reid S, Minden MD.
    Leuk Res; 2005 Dec; 29(12):1381-6. PubMed ID: 15927253
    [Abstract] [Full Text] [Related]

  • 2. Imatinib compared with chemotherapy as front-line treatment of elderly patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL).
    Ottmann OG, Wassmann B, Pfeifer H, Giagounidis A, Stelljes M, Dührsen U, Schmalzing M, Wunderle L, Binckebanck A, Hoelzer D, GMALL Study Group.
    Cancer; 2007 May 15; 109(10):2068-76. PubMed ID: 17429836
    [Abstract] [Full Text] [Related]

  • 3. High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: a phase II study by the Japan Adult Leukemia Study Group.
    Yanada M, Takeuchi J, Sugiura I, Akiyama H, Usui N, Yagasaki F, Kobayashi T, Ueda Y, Takeuchi M, Miyawaki S, Maruta A, Emi N, Miyazaki Y, Ohtake S, Jinnai I, Matsuo K, Naoe T, Ohno R, Japan Adult Leukemia Study Group.
    J Clin Oncol; 2006 Jan 20; 24(3):460-6. PubMed ID: 16344315
    [Abstract] [Full Text] [Related]

  • 4. The achievement of molecular complete remission during treatment with imatinib mesylate correlates with relapse-free survival in bcr/abl-positive acute lymphoid leukemia patients.
    Piccaluga PP, Malagola M, Amabile M, Rondoni M, Paolini S, Pane F, Russo D, Visani G, Baccarani M, Martinelli G.
    Haematologica; 2004 Oct 20; 89(10):1269-71. PubMed ID: 15477218
    [Abstract] [Full Text] [Related]

  • 5. Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR-ABL--positive acute lymphoblastic leukemia-retrospective analysis of Polish Adult Leukemia Group (PALG).
    Wrzesień-Kuś A, Robak T, Pluta A, Zwolińska M, Wawrzyniak E, Wierzbowska A, Skotnicki A, Jakubas B, Hołowiecki J, Nowak K, Kuliczkowski K, Mazur G, Haus O, Dmoszyńska A, Adamczyk-Cioch M, Jedrzejczak WW, Paluszewska M, Konopka L, Pałynyczko G.
    Ann Hematol; 2006 Jun 20; 85(6):366-73. PubMed ID: 16523310
    [Abstract] [Full Text] [Related]

  • 6. [Molecular response and prognostic factors of patients with Philadelphia chromosome/BCR-ABL-positive acute lymphoblastic leukemia treated by imatinib with chemotherapy].
    Wang J, Huang X, Jiang B, Qin Y, Bao L, Jiang H, Chen H, Jia J, Yang S, Jiang Q.
    Zhonghua Xue Ye Xue Za Zhi; 2014 Feb 20; 35(2):120-5. PubMed ID: 24606652
    [Abstract] [Full Text] [Related]

  • 7. [Clinical characteristics and outcomes of 59 patients with acute lymphoblastic leukemia positive for BCR/ABL].
    Liu Z, Liu XL, Du QF, Xu N, Zhong M, Song LL, Yi ZS, Liu QF, Meng FY, Zhou SY.
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar 20; 29(3):512-5. PubMed ID: 19304540
    [Abstract] [Full Text] [Related]

  • 8. Long-term remission in BCR/ABL-positive AML-M6 patient treated with Imatinib Mesylate.
    Pompetti F, Spadano A, Sau A, Mennucci A, Russo R, Catinella V, Franchi PG, Calabrese G, Palka G, Fioritoni G, Iacone A.
    Leuk Res; 2007 Apr 20; 31(4):563-7. PubMed ID: 16916543
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of imatinib mesylate as maintenance therapy in adults with acute lymphoblastic leukemia in first complete remission.
    Potenza L, Luppi M, Riva G, Marasca R, Martinelli S, Torelli G.
    Haematologica; 2005 Sep 20; 90(9):1275-7. PubMed ID: 16154854
    [Abstract] [Full Text] [Related]

  • 10. [Acute lymphoblastic leukemias with aberrations of BCR-ABL genes].
    Parovichnikova EN, Savchenko VG, Verniuk MA, Vinogradova OA, Misiurin AV, Vorob'ev IA, Domracheva EV, Tikhonova LIu, Rukavitsyn OA, Rossiev VA, Kliasova GA, Turkina AG, Liubimova LS, Mendeleeva LP, Isaev VG.
    Ter Arkh; 2005 Sep 20; 77(7):11-6. PubMed ID: 16116902
    [Abstract] [Full Text] [Related]

  • 11. [Successful induction and long-term molecular remission with imatinib mesylate and chemotherapy in a case of Ph-positive acute lymphoblastic leukemia].
    Hirayama Y, Sakamaki S, Takayanagi N, Tsuji Y, Sagawa T, Chiba H, Maeda M, Matsunaga T, Kato J, Niitsu Y.
    Rinsho Ketsueki; 2003 May 20; 44(5):334-8. PubMed ID: 12822409
    [Abstract] [Full Text] [Related]

  • 12. Chemotherapy-phased imatinib pulses improve long-term outcome of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: Northern Italy Leukemia Group protocol 09/00.
    Bassan R, Rossi G, Pogliani EM, Di Bona E, Angelucci E, Cavattoni I, Lambertenghi-Deliliers G, Mannelli F, Levis A, Ciceri F, Mattei D, Borlenghi E, Terruzzi E, Borghero C, Romani C, Spinelli O, Tosi M, Oldani E, Intermesoli T, Rambaldi A.
    J Clin Oncol; 2010 Aug 01; 28(22):3644-52. PubMed ID: 20606084
    [Abstract] [Full Text] [Related]

  • 13. Treatment of adults with BCR-ABL negative acute lymphoblastic leukaemia with a modified paediatric regimen.
    Storring JM, Minden MD, Kao S, Gupta V, Schuh AC, Schimmer AD, Yee KW, Kamel-Reid S, Chang H, Lipton JH, Messner HA, Xu W, Brandwein JM.
    Br J Haematol; 2009 Jun 01; 146(1):76-85. PubMed ID: 19438471
    [Abstract] [Full Text] [Related]

  • 14. The extent of minimal residual disease reduction after the first 4-week imatinib therapy determines outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Lee S, Kim YJ, Chung NG, Lim J, Lee DG, Kim HJ, Min CK, Lee JW, Min WS, Kim CC.
    Cancer; 2009 Feb 01; 115(3):561-70. PubMed ID: 19117346
    [Abstract] [Full Text] [Related]

  • 15. Not all imatinib resistance in CML are BCR-ABL kinase domain mutations.
    Wei Y, Hardling M, Olsson B, Hezaveh R, Ricksten A, Stockelberg D, Wadenvik H.
    Ann Hematol; 2006 Dec 01; 85(12):841-7. PubMed ID: 17006667
    [Abstract] [Full Text] [Related]

  • 16. [Monitoring bcr/abl mRNA levels in imatinib mesylate treated chronic myeloid leukemia patients by real-time quantitative RT-PCR].
    Qin YZ, Ruan GR, Liu YR, Li JL, Fu JY, Wang H, Chang Y, Jiang B, Jiang Q, Jiang H, Qiu JY, Chen SS, Lu DP.
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jan 01; 26(1):1-5. PubMed ID: 15946498
    [Abstract] [Full Text] [Related]

  • 17. Comparison between patients with Philadelphia-positive chronic phase chronic myeloid leukemia who obtained a complete cytogenetic response within 1 year of imatinib therapy and those who achieved such a response after 12 months of treatment.
    Iacobucci I, Rosti G, Amabile M, Poerio A, Soverini S, Cilloni D, Testoni N, Abruzzese E, Montefusco E, Ottaviani E, Iuliano F, Russo D, Gobbi M, Alimena G, Martino B, Terragna C, Pane F, Saglio G, Baccarani M, Martinelli G.
    J Clin Oncol; 2006 Jan 20; 24(3):454-9. PubMed ID: 16421422
    [Abstract] [Full Text] [Related]

  • 18. [Prognostic significance of Ph-positive acute lymphoblastic leukemia].
    Zhou L, Hu J, Chen J, Du S, Wang A, You J, Wu W, Shen Z, Li J.
    Zhonghua Xue Ye Xue Za Zhi; 2014 Feb 20; 35(2):109-13. PubMed ID: 24606650
    [Abstract] [Full Text] [Related]

  • 19. Molecular remission in chronic myeloid leukemia patients with sustained complete cytogenetic remission after imatinib mesylate treatment.
    Colombat M, Fort MP, Chollet C, Marit G, Roche C, Preudhomme C, Reiffers J, Praloran V, Mahon FX.
    Haematologica; 2006 Feb 20; 91(2):162-8. PubMed ID: 16461299
    [Abstract] [Full Text] [Related]

  • 20. Sustained remissions and low rate of BCR-ABL resistance mutations with imatinib treatment chronic myelogenous leukemia in patients treated in late chronic phase: a 5-year follow up.
    Hess G, Meyer RG, Schuch B, Bechthold K, El-Kholy I, Huber C.
    Am J Hematol; 2008 Mar 20; 83(3):178-84. PubMed ID: 17876770
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.